Aurinia Pharmaceuticals Inc (AUPH) SEC 13F Holdings (Q2 2026) — Net Institutional Activity: $192.0M

AUPH ranks #2252 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

AUPH is a top-conviction position for Tang Capital Management LLC — at 10.1% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

State of Alaska, Department of Revenue has added to its AUPH position for two straight quarters, increasing it by $190.0K to reach $316.0K today.

Concurrent Investment Advisors, LLC has trimmed its AUPH position for two straight quarters, cutting it by $65.9K while still holding $401.3K.

AUPH is down 1.3% today, but institutions show net buying of $192.0M this quarter — a divergence between today's price move and the underlying institutional flow.

AUPH posted net income of $314.1M over the trailing twelve months, and currently trades at a P/E of 7.3.

• Profitable — net income of $314.1M over the trailing twelve months
• Revenue grew 19.8% year over year
• Net income improved year over year, from $60.6M to $314.1M
• Generated $135.7M in positive operating cash flow
• Current ratio of 5.25x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.29x equity — within a conventional range